NDC 71656-021-30 - POTASSIUM CHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71656-021
- Requested NDC
- 71656-021-30
- Package NDCs from labels
- 71656-021-16, 71656-021-15, 71656-021-50, 71656-021-01, 71656-021-30, 71656-021-51, 71656-021-02
- Manufacturer
- American Health Packaging
- Effective date
- 2026-09-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POTASSIUM CHLORIDE - American Health Packaging | American Health Packaging | 2026-09-23 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - Saptalis Pharmaceuticals, LLC | Saptalis Pharmaceuticals, LLC | 2026-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-08-24 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2025-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71656-021-01 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-01 | POTASSIUM CHLORIDE | 10 in 1 CASE | SOLUTION | 10 | 5 | |
| 71656-021-02 | POTASSIUM CHLORIDE | 10 in 1 CASE | SOLUTION | 10 | 5 | |
| 71656-021-02 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-15 | POTASSIUM CHLORIDE | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 5 | |
| 71656-021-16 | POTASSIUM CHLORIDE | 473 mL in 1 BOTTLE | SOLUTION | 473 | 5 | |
| 71656-021-30 | POTASSIUM CHLORIDE | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 5 | |
| 71656-021-50 | POTASSIUM CHLORIDE | 5 in 1 CASE | SOLUTION | 5 | 5 | |
| 71656-021-50 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-51 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-51 | POTASSIUM CHLORIDE | 5 in 1 CASE | SOLUTION | 5 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71656-021-01 | ML - Milliliter | 71656-021 | 6bd0ebbf-a7a4-40f2-b463-9f94ddbce7be | 1 | 2024-06-10 |
| 71656-021-15 | ML - Milliliter | 71656-021 | c27304b6-be2d-4797-aac3-a530ab28e3ba | 1 | 2024-06-10 |
| 71656-021-16 | ML - Milliliter | 71656-021 | 99d9cda5-bc17-4912-b16e-3b4dd995bd14 | 1 | 2024-08-12 |
| 71656-021-30 | ML - Milliliter | 71656-021 | 0b65870e-cf13-427b-af5f-c812d5eb9e9c | 1 | 2025-05-14 |
| 71656-021-50 | ML - Milliliter | 71656-021 | b55652f8-ada5-4d3a-a114-b9e2fbac018c | 1 | 2023-12-05 |
| 71656-021-51 | ML - Milliliter | 71656-021 | 5d529fbd-3765-4e17-9818-571896c812e3 | 1 | 2023-12-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| Clear Eyes Cooling Redness Relief | GLYCERIN AND NAPHAZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 38d14e99-e4c8-431b-b106-578eeb38bf3c | 2026-10-15 | Warnings | PDC6A3C0OX |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | PDC6A3C0OX |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | cc15ef60-6956-4d34-b86d-72cdd0c0c0bb | 2026-10-14 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | ccaaa3a2-a273-41c7-9e54-429539ea0140 | 2026-10-14 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 018fc687-1fba-202e-e063-6294a90a5c9a | 2026-10-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON M | POTASSIUM CHLORIDE | Cardinal Health 107, LLC | ee3a1815-7325-4838-9764-fe1db68877b6 | 2026-10-13 | Warnings, Adverse reactions | 660YQ98I10 |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 727be945-df2a-4fbf-ade4-f242e2647976 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 302b3fa7-ea87-4bf1-aae0-6a2d7459de86 | 2026-10-08 | Warnings, Adverse reactions | 314182 312515 660YQ98I10 |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.